ResearcherHarbin Institute of TechnologyActive in the last 2 years

Huan Nie

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9221-1283; OpenAlex author ID A5101821612. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

SLC7A11-AS1 contributes to prolonged activation of activin A/Smad signaling by suppressing PPM1A myristoylation in pancreatic cancer. Co-author DOI 10.1038/s41416-025-03149-4 ↗
Novel Metabolomics Serum Biomarkers for Pancreatic Ductal Adenocarcinoma by the Comparison of Pre-, Postoperative and Normal Samples. Last author DOI 10.7150/jca.41250 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Huanjie Yang · 1 shared paper, 2025 · strength 0.27
- Paper SLC7A11-AS1 contributes to prolonged activation of activin A/Smad signaling by suppressing PPM1A myristoylation in panc… DOI 10.1038/s41416-025-03149-4 ↗
Kai Li · 1 shared paper, 2025 · strength 0.27
- Paper SLC7A11-AS1 contributes to prolonged activation of activin A/Smad signaling by suppressing PPM1A myristoylation in panc… DOI 10.1038/s41416-025-03149-4 ↗
Qingzhu Yang · 1 shared paper, 2025 · strength 0.27
- Paper SLC7A11-AS1 contributes to prolonged activation of activin A/Smad signaling by suppressing PPM1A myristoylation in panc… DOI 10.1038/s41416-025-03149-4 ↗
Mengmeng Li · 1 shared paper, 2025 · strength 0.27
- Paper SLC7A11-AS1 contributes to prolonged activation of activin A/Smad signaling by suppressing PPM1A myristoylation in panc… DOI 10.1038/s41416-025-03149-4 ↗
Xiaohan Zhang · 1 shared paper, 2020 · strength 0.10
- Paper Novel Metabolomics Serum Biomarkers for Pancreatic Ductal Adenocarcinoma by the Comparison of Pre-, Postoperative and N… DOI 10.7150/jca.41250 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.